SEARCH

MEDIA PACK

NEWS

Current Edition

Cancer Research Center

Fred Hutch researchers tout Iclusig’s potential to tame cytokine storm in COVID but can’t get Takeda on board

Researchers at the Fred Hutchinson Cancer Research Center in Seattle say they have uncovered an FDA-approved drug that may be effective in combating the often-lethal …

16 September 2021 Regional News Cancer Research Center cytokine

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

Fred Hutch researchers tout Iclusig’s potential to tame cytokine storm in COVID but can’t get Takeda on board

Journal for Clinical Studies